Technology

Flow control valve launched that can form part of ventilators

The new VEMD proportional flow control valve from Festo uses the latest piezo technology to deliver dynamic control for numerous medical and other industrial control applications. The VEMD is a mass flow controller integrating a flow sensor with a proportional valve and controller and is designed to proportionally control the flow of compressed air and inert gases within a small, neat and calibrated package. It compares the required signal value with the actual, sensor-measured value within its closed loop electronic controller and then adjusts the output using the piezo pilot valve. The piezo pilot valve provides a wide variety of advantages including silent operation, the absence of heat generation, a compact and lightweight design and long service life – as well as an unmatched low powe...

How is COVID-19 affecting the NHS customer environment?

Oli Hudson, content director at Wilmington Healthcare, explores some of seismic changes happening in the NHS, looked at through an industry lens. Sea changes in the way the NHS customer environment is operating are happening right now as a result of the pandemic. In a recently published white paper by Wilmington Healthcare, COVID-19 and the NHS customer environment, I look at all of these. A rapid pace and a huge scale are the twin hallmarks of these developments, which are affecting NHS structure, organisation and integration, NHS finance and budgeting, long-term conditions management, the NHS’s relationship with the private sector, changes to care pathways, NHS digital transformation, acute care reconfiguration and of course industry engagement. My colleague Dave West, deputy editor at H...

AI application launched for COVID-19 pneumonia detection

BioMind has launched an artificial intelligence (AI) application to assist in the detection of COVID-19 associated pneumonia on medical imaging.  The AI application identifies anomalies in the lungs and assists in detection of COVID-19 pneumonia. It analyses the lung pathology on chest CT to aid in the assessment and comes with triage capability. With the sudden surge in admission of respiratory-related patients globally, triaging can help to reduce the increasing burden on the intensive care units (ICU) and address the shortage of medical resources.  Raymond Moh, CEO of BioMind, said: “We are proud to receive the Health Sciences Authority’s approval for our COVID-19 diagnostics support product. This was born out of the immense efforts and collaborations between clinicians, lung ...

AdvaMed issues COVID-19 compliance guidance

The Advanced Medical Technology Association (AdvaMed) has issued a “Code of Ethics Compliance Guidance Related to the COVID-19 Response.” Christopher L White, AdvaMed COVID action team leader, chief operating officer and general counsel, said: “This guidance seeks to help AdvaMed members and other medical technology companies develop and implement processes that both support rapid decision-making in the context of the pandemic and mitigate any related compliance risks. “As medtech companies supporting the public health response to COVID-19 work around the clock to produce essential medical products to help prevent, detect and treat this disease, we must continue to do all we can to help ensure patients are provided both timely and ethical access to our equipment, knowledge and trained pers...

How testing systems need to evolve so the next pandemic never happens

Nicolas Vergauwe, chief executive officer of miDiagnostics, shares his thoughts on how the global diagnostic landscape should change in response to COVID-19. The question of when and how to test those infected with COVID-19 has become of paramount importance as the pandemic has gained momentum across the world, with over four million cases reported to date. International governments are struggling to cope with the demand for increased testing capacity within already stretched healthcare systems. The industry has therefore been working tirelessly to develop and supply clinicians with novel tests to try and cope with the backlog. Yet this difficulty in addressing testing capacity is prompting a more fundamental discussion on whether our diagnostics testing model is fit for purpose, especiall...

Orexo secures US rights to digital mental health therapy

Orexo has acquired the US rights to GAIA’s deprexis, a digital therapy to help patients manage symptoms of depression. The announcement follows two earlier agreements with GAIA where Orexo acquired the exclusive US commercial rights to solutions which helps reduce risky drinking patterns in adults with alcohol use disorder and for the treatment of opioid use disorder (OUD). The need for digital therapies due to the COVID-19 crisis is unprecedented. The COVID-19 crisis and the actions taken could result in a significant rise in mental illness. The recent emergency use authorisation policy for digital health devices for treating psychiatric disorders published by the US Food and Drug Administration (FDA) will allow Orexo to accelerate the launch of its three digital therapies in 20...

FDA approves AI algorithms detecting signs of COVID-19

AI solutions provider for radiologists, Aidoc, has received clearance from the FDA for its AI algorithms intended for adjunctive use in the detection of findings associated with COVID-19. The product detects and prioritises incidental CT findings associated with COVID-19 (e.g. GGO – a non-specific imaging finding associated with COVID-19 infection) in any CT study that contains the lung or part of the lung – for example chest, abdomen or cervical spine. Prioritisation of these incidental findings may help manage the adverse effects of COVID-19 by providing adjunctive information that can promote further patient evaluation.   Dr. Paul Chang, vice chair, Radiology Informatics at University of Chicago Medicine, said: “In our experience, it is not unusual for the radiolog...

COVID-19 antibody self-test ready for mass production in June

Diagnostic technologies developer Mologic has joined forces with BioSure, self-testing specialists, to produce a COVID-19 antibody self-test. By combining Mologic’s COVID-19 lateral flow test with BioSure’s design, the companies have created a self-test for COVID-19 that can be used without any training being required. The design has been proven to be easy to use, requires only a fraction of a drop of blood and gives the user their own result in 10 minutes. Since launching the first CE marked HIV self-test in 2015, BioSure have become world-leading experts in self-testing. Mark Davis, CEO, Mologic: “Mologic is thrilled to be partnering with BioSure on this COVID-19 self-test, which will enable people to quickly and safely test for antibodies to the virus in their own home. The team an...

New batch of ventilators arrive in UK as Ventilator Challenge review continues

A batch of 150 ventilators devices, made up of the Vivo65 and Nippy4+ ventilators from Breas Medical has arrived in the UK from Sweden. The ventilators are existing designs, already approved by regulators. The Cabinet Office says it has assisted Breas, who also operate in Stratford-Upon-Avon, to ramp up the production of its ventilators, by supporting new production lines, negotiating with suppliers to source critical components and expediting shipments of key parts from around the world. The government has ordered 2000 of the devices, with hundreds expected to arrive over the coming weeks. The Vivo65 and the Nippy4+ ventilators join the Penlon Prima ESO2 and the Smiths paraPAC models as Ventilator Challenge devices which are available to the NHS. The Cabinet Office has said that, fol...

Imperial College London receives €500k for COVID-19 test

A team led by Imperial College London will receive support and over €500,000 from EIT Health as part of a COVID-19 ‘Rapid Response’ drive from the EU network. The team at Imperial, alongside partners from Imperial College Healthcare NHS Trust, the London School of Hygiene and Tropical Medicine and Abingdon Health, will develop a rapid and ultrasensitive point-of-care diagnostic test for the virus.  The consortium will develop the test, ‘QwikZyme’, over the next six months. The test is designed to be able to detect ultra-low concentrations of the virus itself, with the aim of earlier diagnosis – and results within an hour.  QwikZyme lead, Professor Molly Stevens, said: “SARS-CoV-2 is an unprecedented challenge on healthcare systems worldwide. Since last December, the virus has spr...

Combining camera and inertial data to optimise human movement

Kim Duffy, life science product manager at Vicon, discusses the uses of motion capture technology in medtech.  Over the last decade, the use of motion capture technology by sporting bodies, research institutions and scientists across the globe has risen significantly. Motion capture was first used in the life science market for gait analysis in the early 1970s. Forty-or-so years later, biomechanics research remains the technology’s most common application. The technology has made waves in academic and medical research and is at the frontline of cutting-edge clinical movement research. It is critical to the work of leading research centres, universities, hospitals and private medical practices across the globe, and is helping in various ways, from the rehabilitation of wounded soldiers...

DC motors provider brings integrated speed controller to market

DC motors provider Faulhaber has brought a new integrated speed controller for flat motors to market. The BXT motor family, consisting of brushless DC-servomotors with short design, was expanded in all sizes with a diameter-compliant, integrated speed controller. With an additional attachment length of 6.2 mm, the motor/speed controller combinations are available with the same installation space as the products with the IEF3-4096 (L) integrated encoder. Through the use of synergy effects with the encoder variants, the Speed Controller is likewise fully integrated in the motor housing. Based on the Faulhaber SC technology, the motors can be put into operation with the Motion Manager (from version 6.6). The Speed Controller is connected to the application with a six-pole flat cable...